CRO Medpace is doubling its capacity for Phase I studies at its Cincinnati facility, adding a 96-bed clinical pharmacology unit. The development follows what appears to be a trend among CROs, Outsourcing-Pharma notes, as many large companies are opening in-patient facilities designed to house early-stage trials. Report